About Us
Disclaimer
Contact
Write a Post
EN
|
CH
|
ES
Log in
Register
Don't have an account yet?
Register now!
Username *
Password *
"Sign in" above to accept KNOWPIA’s
Terms of Conditions
&
Privacy Policy
Forgot your password?
Fields marked with an asterisk (*) are required.
Username/Email *
Password *
Confirm Password *
Email *
Referral Code
I’ve read and accept the
Terms and Conditions
Register
BREAKING NEWS
Cloud Server Hosting For Online Businesses
Inexpensive SEO Services
Benefits of Wanting to play Free Online Slot machines
KNOWPIA
WELCOME TO KNOWPIA
KNOWPIA
HOME
KNOWPEDIA
KNOWMEDIA
Lifestyle
Money
Sports & Entertainment
Politics
Health & Fitness
Tech
Food
Other
HOW IT WORKS
INNA-051
Summary
INNA-051
is a
COVID-19 vaccine
candidate developed by Ena Respiratory.
[1]
[2]
INNA-051
Clinical data
Routes of
administration
Intranasal
References
edit
^
"INNA-051 intranasal safety and tolerability study".
anzctr.org.au
. 21 April 2021. ACTRN12621000607875p
. Retrieved
20 May
2021
.
^
Clinical trial number
NCT05118763
for "Intranasal INNA-051 for Prevention of COVID-19 in Adults" at
ClinicalTrials.gov
Scholia has a profile for
INNA-051
(Q110269792)
.
Portals:
Medicine
Viruses
COVID-19